Financhill
Sell
44

HSIC Quote, Financials, Valuation and Earnings

Last price:
$69.98
Seasonality move :
4.99%
Day range:
$69.46 - $70.75
52-week range:
$63.67 - $82.63
Dividend yield:
0%
P/E ratio:
28.71x
P/S ratio:
0.72x
P/B ratio:
2.49x
Volume:
1.1M
Avg. volume:
1.8M
1-year change:
-6.49%
Market cap:
$8.7B
Revenue:
$12.3B
EPS (TTM):
$2.44

Analysts' Opinion

  • Consensus Rating
    Henry Schein has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of --, Henry Schein has an estimated upside of 6.81% from its current price of $70.06.
  • Price Target Downside
    According to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $70.06.

Fair Value

  • According to the consensus of 0 analysts, Henry Schein has 6.81% upside to fair value with a price target of -- per share.

HSIC vs. S&P 500

  • Over the past 5 trading days, Henry Schein has underperformed the S&P 500 by -8.35% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Henry Schein does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Henry Schein has grown year-over-year revenues for 3 quarters straight. In the most recent quarter Henry Schein reported revenues of $3.2B.

Earnings Growth

  • Henry Schein earnings have been falling on a year-over-year basis for 9 quarters in a row. In the most recent quarter Henry Schein reported earnings per share of $0.78.
Enterprise value:
12.7B
EV / Invested capital:
1.67x
Price / LTM sales:
0.72x
EV / EBIT:
24.20x
EV / Revenue:
1.02x
PEG ratio (5yr expected):
--
EV / Free cash flow:
30.24x
Price / Operating cash flow:
21.47x
Enterprise value / EBITDA:
15.62x
Gross Profit (TTM):
$3.9B
Return On Assets:
3.06%
Net Income Margin (TTM):
2.51%
Return On Equity:
6.21%
Return On Invested Capital:
4.24%
Operating Margin:
6.46%
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Income Statement
Revenue $12.6B $12.7B $12.5B $3.2B $3.2B
Gross Profit $3.8B $3.9B $3.9B $995M $993M
Operating Income $890M $828M $599M $211M $205M
EBITDA $1.1B $893M $815M $273M $236M
Diluted EPS $4.60 $3.38 $2.44 $1.05 $0.78
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Balance Sheet
Current Assets $3.9B $3.9B $4B $4.1B $4.1B
Total Assets $7.8B $8.4B $8.5B $9.8B $10.6B
Current Liabilities $2.6B $2.3B $2.1B $2.1B $2.9B
Total Liabilities $3.7B $3.7B $3.7B $4.7B $5.6B
Total Equity $4.1B $4.7B $4.8B $5.1B $5B
Total Debt $1.1B $774.6M $1B $1.9B $2.7B
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Cash Flow Statement
Cash Flow Operations $625M $786M $612M $231M $151M
Cash From Investing -$409M -$873M -$699M -$468M -$91M
Cash From Financing -$200M $113M $88M $248M -$41M
Free Cash Flow $495M $587M $421M $181M $107M
HSIC
Sector
Market Cap
$8.7B
$45.6M
Price % of 52-Week High
84.79%
45.55%
Dividend Yield
0%
0%
Shareholder Yield
1.47%
-0.74%
1-Year Price Total Return
-6.49%
-31.35%
Beta (5-Year)
0.870
0.772
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Sell
Level $72.67
200-day SMA
Sell
Level $70.81
Bollinger Bands (100)
Sell
Level 68.45 - 73.79
Chaikin Money Flow
Buy
Level 153.4M
20-day SMA
Sell
Level $74.42
Relative Strength Index (RSI14)
Sell
Level 40.26
ADX Line
Sell
Level 17.3
Williams %R
Buy
Level -83.5264
50-day SMA
Sell
Level $72.21
MACD (12, 26)
Sell
Level -0.50
25-day Aroon Oscillator
Sell
Level -64
On Balance Volume
Neutral
Level 139.3M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (3.1626)
Buy
CA Score (Annual)
Level (-0.2597)
Buy
Beneish M-Score (Annual)
Level (-2.2728)
Buy
Momentum Score
Level (5)
Buy
Ohlson Score
Level (-0.6262)
Buy
Piotroski F Score (Annual)
Level (5)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (9)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services primarily to office-based dental and medical practitioners, as well as alternate sites of care. The company operates in two reportable segments; health care distribution and technology & value-added services. The healthcare distribution segment is engaged in combining global dental and medical businesses and distributes consumable products, small equipment, laboratory products, and Vitamins. The technology and value-added services reportable segment provides software, technology & other value-added services to health care practitioners. The majority of revenue is derived from the health care distribution segment.

Stock Forecast FAQ

In the current month, HSIC has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The HSIC average analyst price target in the past 3 months is --.

  • Where Will Henry Schein Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Henry Schein share price will rise to -- per share over the next 12 months.

  • What Do Analysts Say About Henry Schein?

    Analysts are divided on their view about Henry Schein share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Henry Schein is a Sell and believe this share price will drop from its current level to --.

  • What Is Henry Schein's Price Target?

    The price target for Henry Schein over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is HSIC A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Henry Schein is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of HSIC?

    You can purchase shares of Henry Schein via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Henry Schein shares.

  • What Is The Henry Schein Share Price Today?

    Henry Schein was last trading at $69.98 per share. This represents the most recent stock quote for Henry Schein. Yesterday, Henry Schein closed at $70.06 per share.

  • How To Buy Henry Schein Stock Online?

    In order to purchase Henry Schein stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Alphabet an Undervalued Growth Stock to Buy?
Is Alphabet an Undervalued Growth Stock to Buy?

Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…

Is Tesla Going to Buy Uber?
Is Tesla Going to Buy Uber?

Tesla has always been in the habit of making large,…

NVIDIA vs Broadcom Stock: Which Is Best?
NVIDIA vs Broadcom Stock: Which Is Best?

If you want to invest in an AI-leading tech company,…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 42x

Buy
57
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
52
TSLL alert for Dec 24

Direxion Daily TSLA Bull 2X Shares [TSLL] is up 19.46% over the past day.

Buy
73
PSIX alert for Dec 24

Power Solutions International [PSIX] is up 27.42% over the past day.

Sell
31
SOXL alert for Dec 24

Direxion Daily Semiconductor Bull 3X Shares [SOXL] is up 11.87% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock